Bank of Montreal’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Bank of Montreal's PFE Position: Q2 2026 in Review
Bank of Montreal increased its Pfizer (PFE) stake by 6.5% in Q2 2026, buying an estimated $13.1M and bringing the position to 8,168,120 shares worth $197M. The position accounts for 0.06% of the portfolio, ranked #239.
Bank of Montreal first reported a position in PFE in Q2 2013 and has held it in 53 quarters since. The position peaked at $971M in Q3 2018. 2,840 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Bank of Montreal held 8,168,120 shares of Pfizer worth $197M as of Q2 2026.
- Bank of Montreal bought 500,715 Pfizer shares in Q2 2026, an estimated $13.1M.
- Pfizer made up 0.06% of Bank of Montreal's portfolio in Q2 2026, its #239 holding.
- Bank of Montreal first reported a position in Pfizer in Q2 2013 and has held it in 53 quarters since.
- Bank of Montreal's Pfizer position peaked at $971M in Q3 2018.
- 2,840 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.